Skip to main content


Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation

Fig. 3

Effects of Citral on systemic T cell and B cell activation and intracellular staining of T lymphocytes from the spleen for IFN-γ or IL-4 in a mouse model. a-d Percentage of systemic CD3+ T cells (a), CD4+ T cells (b), CD8+ T cells (c), or CD19+ B cells (d) expressing the activation marker CD69. e and f Percentage of spleen CD3+ T cells expressing IFN-γ+ (e) or IL-4+ (f). Bars show mean ± standard error of the mean for 7 mice per group; *p <0.05, ***p <0.005, ns not significant. ALSN accelerated and severe lupus nephritis

Back to article page